Abstract
The reactivation of mycobacterium infection inrenal transplant recipients in developingcountries is a common therapeutic dilemma,especially in those patients receivingcyclosporin immunosuppression. The inclusion ofrifampicin in the antituberculosis protocolincreases the risk of precipitating acuteallograft rejection due to its interaction withcyclosporin and also increases the financialburden. We successfully treated 16 patients whodeveloped mycobacterial infection post renaltransplant with a rifampicin sparingantituberculosis drug regimen. Pyrexia ofunknown origin was the most common manifestationobserved and a therapeutic trial withantituberculosis drugs is justified. De novodiabetes mellitus appears to be an added riskfactor and increases the susceptibility tomycobacterial infection.
Similar content being viewed by others
References
Cohen J, Hopkin J, Kurtz J. Infectious complications after renal transplantation. In: Morris PJ, ed. Kidney transplantation Principles and Practice (3rd ed). W.B. Saunders Company, 1988: 533.
Sakhuja V, Jha V, Varma PP et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211–215.
Rubin RH, Wolfson JS, Cosomi AB, Tolkoff-Rubin NE. Infections in the renal transplant recipient. Am J Med 1981; 70(2): 405–411.
Fauci AS. Corticosteroids and circulating lymphocytes. Transplant Proc 1975; 7: 37–40.
McMillan MA. Clinical pharmacokinetics of cyclosporin. Pharmocol Ther 1989; 42: 135–156.
Udani PM. Tuberculosis. In: Shah JS, ed. API Textbook of Medicine (4th ed) Associations of Physicians of India, 1986: 1091.
Naqvi A, Akhtar F, Naqvi R et al. Problems of diagnosis and treatment of tuberculosis following renal transplantation. Transplant Proc 1997; 29: 3051–3052.
Cengiz K. Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron 1996; 73: 421–424.
Spence RK, Dafoe DC, Rabin G et al. Mycobacterial infections in renal allograft recipients. Arch Surg, 1983; 118(3): 356–359.
Qunibi WY, Al-Sibai MB, Taher S et al. Mycobacterial infection after renal transplantation-report of 14 cases and review of the literature. Q J Med 1990; 77(282): 1039–1060.
Lloveras J, Peterson PK, Simmons PL, Najarian JS. Mycobacterial infections in renal transplant recipients. Seven cases and review of the literature. Arch Intern Med 1982; 142: 888–892.
Ascher NL, Simmons RL, Marker S et al. Tubrculous joint disease in renal transplant patients. Am J Surg 1978; 135(6): 853–856.
Al-Sulaiman MH, Dhar JM, Al-Khader. Transplantation 1990; 50(4): 597–598.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vachharajani, T.J., Oza, U.G., Phadke, A.G. et al. Tuberculosis in renal transplant recipients: Rifampicin sparing treatment protocol. Int Urol Nephrol 34, 551–553 (2002). https://doi.org/10.1023/A:1025693521582
Issue Date:
DOI: https://doi.org/10.1023/A:1025693521582